Recruiting studies: Congenital Adrenal Hyperplasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
EARLY_Phase 1 · 1 location(s) · University of Virginia · NCT04723862 Natural History Study of Patients With Excess Androgen
Phase N/A · 2 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT00250159 FEmale Metabolic Risk and Androgens: an Irish Longitudinal (FEMAIL) Study
Phase N/A · 1 location(s) · Royal College of Surgeons, Ireland · NCT04912648 Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Phase 2 · 1 location(s) · Mayo Clinic · NCT07104812 Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06754423 Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate
Phase 1/Phase 2 · 1 location(s) · University Medical Center Groningen · NCT06616142 Hyperandrogenemia and Altered Day-night LH Pulse Patterns
EARLY_Phase 1 · 1 location(s) · University of Virginia · NCT03068910 Fertility And Sexual Function In CAH: CALLIOPE
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT07099456 A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
Phase 1/Phase 2 · 17 location(s) · H. Lundbeck A/S · NCT05669950 Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Phase 4 · 1 location(s) · Johns Hopkins University · NCT07247058 Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS
NA · 1 location(s) · Behnood Abbasi · NCT07298564 Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07473804 A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
Phase 2/Phase 3 · 43 location(s) · Crinetics Pharmaceuticals Inc. · NCT07159841 Non Invasive Imaging Methods for Detecting PA：a Clinical PET Study of 18F-Pentixather
NA · 1 location(s) · Fangfang Sun · NCT06581744 Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS
Phase N/A · 1 location(s) · Attikon Hospital · NCT06889454 Parenting and CAH - 21-hydroxylase Deficiency
Phase N/A · 4 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06900153 Body Fat as Determinant of Female Gonadal Dysfunction
Phase N/A · 1 location(s) · Fundacion para la Investigacion Biomedica del Hospital Unive · NCT03841981 Dexamethasone and Pregnancy: Maternal Effects
Phase N/A · 17 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06259994 Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without
EARLY_Phase 1 · 1 location(s) · University of Virginia · NCT00929006 GROWing Up With Rare GENEtic Syndromes
Phase N/A · 1 location(s) · dr. Laura C. G. de Graaff-Herder · NCT04463316 Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
Phase 4 · 1 location(s) · Federico II University · NCT03760835 Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study
Phase N/A · 1 location(s) · Guangzhou Women and Children's Medical Center · NCT03742011 Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723 An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia
Phase 2 · 13 location(s) · Crinetics Pharmaceuticals Inc. · NCT06712823 Acupuncture or Metformin for Insulin Resistance in Women With PCOS
Phase 2 · 2 location(s) · Karolinska Institutet · NCT02647827 A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
Phase 3 · 55 location(s) · Crinetics Pharmaceuticals Inc. · NCT07144163

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.